The 24th Annual Scientific Retreat

The 24th Annual Prostate Cancer Foundation Scientific Retreat will be held at the Omni Shoreham Hotel in Washington, DC from October 5 - 7, 2017. This event is the foremost scientific conference in the world on the biology and treatment of prostate cancer. The diversity, novelty, and extremely high impact.


The 23rd Annual Scientific Retreat

The 23rd Annual Prostate Cancer Foundation (PCF) Scientific Retreat was held in Carlsbad, CA on October 27-29, 2016. This event is the foremost scientific conference in the world on the biology and treatment of prostate cancer. The diversity, novelty, and extremely high impact of the topics presented as well as.


Empowering Researchers

PCF identifies the most promising research ideas and attracts brilliant individuals and teams of scientists, early in their careers, to PCF’s Research Enterprise. By channeling resources directly to the world’s top scientific minds, PCF is able to cut through red tape, speed scientific breakthroughs and deliver new treatments to patients.


RFA Notification List Sign Up

PCF Research Awards Notification If you would like to be notified when the next research RFA is available, please provide your contact information.


PCF Holiday Cards

2016 PCF Holiday Cards Now Available! PCF announces the 9th annual holiday card collection designed by Jean Fogelberg in loving memory of her husband, musician Dan Fogelberg whose life was affected by prostate cancer. (Available with matching stamps or without.) Buy Now 


PCF and MLB Step Up to the Plate to Raise Awareness and Fund Research for Prostate Cancer

Joe Torre encourages baseball fans everywhere to support PCF’s efforts to end prostate cancer by delivering an important public service announcement, “to step up to the plate, help save lives and get one step closer to finding a cure.”


New Clinical Trial Methods Accelerate Research and Development

Prostate cancer can be slow to progress, frustrating the development of new therapies for patients with early, high-risk disease. New results from ICECaP (Intermediate Clinical Endpoints for Cancer of the Prostate), a PCF-supported initiative led by Dr. Christopher Sweeney, will cut the time required to assess new therapies for aggressive.


Top 5 Discoveries of 2015 Mean More Lives Saved in 2016

2015 was as an exceptional year for science — in particular, genetics-based science that will directly affect the care and improve the outcome for prostate cancer patients worldwide.


The Precision Medicine Revolution

Welcome to the world of precision medicine—where doctors can target each prostate cancer with new, more effective drugs. And this is just the beginning.


Progress Report: Andrew Armstrong, MD, MSc

Investigator: Andrew Armstrong, MD, MSc – Associate Professor, Duke University Linking Epithelial and Stemness Plasticity with Prostate Cancer Metastasis and the Lethal Phenotype The mechanism by which cancer cells spread from the primary tumor to distant sites in the body (the process of metastasis) is not fully understood. Scientists hypothesize.